Orion Oyj
OTC:ORINF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of Orion Oyj (ORINF) under the Base Case is USD per share. Compared with the current market price of 115.6 USD, the stock appears .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
What one share is worth in the bear, base and bull cases.
Create a free account · No card needed
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Orion Does
Orion Oyj is a Finnish pharmaceutical company that develops, manufactures, and sells medicines for people and animals. Its main products include prescription drugs, over-the-counter medicines, and veterinary medicines, with a strong focus on treatments for the central nervous system, cancer care, and animal health. The company also makes active pharmaceutical ingredients and other drug-related products that it sells to partners in the healthcare industry.
- Headquarters
- Finland FI
- Employees
- 4 132
- IPO date
- Jul 3, 2006
Balance Sheet
Recent Events
Latest Earnings Call
Nubeqa remained Orion’s key growth driver, and strong first-nine-month performance and outlook for the rest of the year prompted an upgrade to its 2026 financial outlook.
Open the earnings call- EPS
- €1.19
- Expected
- €1.13
- Surprise
- +5.3%
- Stock, day of the call
- +0.2%
Past 12 months
Continue ORINF Research
Decided on Orion? Get an email when ORINF reaches the price you’d buy at. Free with an account.
Other Orion listings
What is the Intrinsic Value of one ORINF stock?
The intrinsic value for Orion Oyj (ORINF) under the Base Case is USD.
Is ORINF stock undervalued or overvalued?
Compared with the current market price of 115.6 USD, the stock appears .